Hikma Pharmaceuticals (LSE:HIK) Short-Term Capital Lease Obligation : £9 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Hikma Pharmaceuticals Short-Term Capital Lease Obligation?

Hikma Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was £9 Mil.

Hikma Pharmaceuticals's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 (£7 Mil) to Jun. 2023 (£8 Mil) and increased from Jun. 2023 (£8 Mil) to Dec. 2023 (£9 Mil).

Hikma Pharmaceuticals's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (£7 Mil) to Dec. 2022 (£7 Mil) and increased from Dec. 2022 (£7 Mil) to Dec. 2023 (£9 Mil).

Hikma Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Hikma Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Short-Term Capital Lease Obligation Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

6.87

7.44

6.77

7.39

8.69

Hikma Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															6.77	7.31	7.39	7.92	8.69

Hikma Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Hikma Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals (LSE:HIK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (LSE:HIK) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HKMPF:USA HIKl:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (LSE:HIK) Headlines

No Headlines